Revenue: The sum of all revenue fields included for a company's operating activities.
Cartesian Therapeutics, Inc. (RNAC) had Revenue of $1.10M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$1.10M |
$-17.71M |
|
-- |
|
$1.10M |
|
$22.99M |
|
$-21.89M |
|
$4.18M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-21.89M |
|
$-20.73M |
|
25.90M |
|
25.90M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$185.12M |
|
$10.17M |
|
$224.01M |
|
$409.13M |
|
$15.00M |
|
-- |
|
$415.92M |
|
$430.92M |
|
$-21.79M |
|
$-69.95M |
|
$-21.79M |
|
25.94M |
|
| Cash Flow Statement Financials | |
$-23.11M |
|
$-1.07M |
|
$-8.03M |
|
$214.28M |
|
$182.10M |
|
$-32.18M |
|
$2.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1989.91% |
|
-1989.91% |
|
-- |
|
-1610.00% |
|
-1610.00% |
|
$-24.18M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.62 |
|
144.41 |
|
81.28% |
|
25.32% |
|
-4.33% |
|
81.28% |
|
$-0.84 |
|
$-0.93 |
|
$-0.89 |
|